Nome |
# |
Considerations on safety and treatment of patients with chronic heart failure at high altitude, file dfa8b991-2f75-748b-e053-3a05fe0a3a96
|
1.547
|
Exercise intolerance in chronic heart failure : mechanisms and therapies. Part I, file dfa8b990-4315-748b-e053-3a05fe0a3a96
|
1.206
|
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease : a meta-analysis, file dfa8b991-2f76-748b-e053-3a05fe0a3a96
|
1.008
|
Documento Cardiologico di Consenso
della Task Force Multisocietaria : la prescrizione dell’esercizio fisico
in ambito cardiologico (Parte prima), file dfa8b990-4f57-748b-e053-3a05fe0a3a96
|
697
|
Acetazolamide and inhaled carbon dioxide reduce periodic breathing during exercise in patients with chronic heart failure, file dfa8b991-2e44-748b-e053-3a05fe0a3a96
|
668
|
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry, file dfa8b99b-63ae-748b-e053-3a05fe0a3a96
|
666
|
Subclinical pulmonary edema in endurance athletes, file dfa8b991-37e7-748b-e053-3a05fe0a3a96
|
660
|
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study, file dfa8b9a3-000d-748b-e053-3a05fe0a3a96
|
643
|
Reference values for peak exercise cardiac output in healthy individuals, file dfa8b997-ac16-748b-e053-3a05fe0a3a96
|
630
|
Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients, file dfa8b98f-8553-748b-e053-3a05fe0a3a96
|
581
|
Role of cardiopulmonary exercise testing in clinical stratification in heart failure : A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology, file dfa8b999-e5d7-748b-e053-3a05fe0a3a96
|
532
|
Exercise training in patients with ventricular assist devices : a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology, file dfa8b99e-6260-748b-e053-3a05fe0a3a96
|
467
|
Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the high altitude cardiovascular research-andes study, file dfa8b993-23fc-748b-e053-3a05fe0a3a96
|
390
|
Periodic Breathing during Incremental Exercise, file dfa8b999-4214-748b-e053-3a05fe0a3a96
|
371
|
You can leave your mask on : Effects on cardiopulmonary parameters of different airway protection masks at rest and during maximal exercise, file dfa8b9a6-d0cd-748b-e053-3a05fe0a3a96
|
357
|
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study, file dfa8b9a3-c9cf-748b-e053-3a05fe0a3a96
|
344
|
Cardiovascular death risk in recovered mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test, file dfa8b9a2-607f-748b-e053-3a05fe0a3a96
|
340
|
COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart, file dfa8b9a8-3f21-748b-e053-3a05fe0a3a96
|
310
|
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation, file dfa8b98f-bfab-748b-e053-3a05fe0a3a96
|
302
|
Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with Levosimendan, file dfa8b99a-c966-748b-e053-3a05fe0a3a96
|
274
|
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research, file dfa8b999-0288-748b-e053-3a05fe0a3a96
|
271
|
Inside ventilatory regulation in pulmonary hypertension: several hidden data are still undiscovered, file dfa8b991-294b-748b-e053-3a05fe0a3a96
|
266
|
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus, file dfa8b9a0-2ef1-748b-e053-3a05fe0a3a96
|
266
|
Heart failure progression in hypertrophic cardiomyopathy - Possible insights from cardiopulmonary exercise testing, file dfa8b997-117d-748b-e053-3a05fe0a3a96
|
252
|
Treatment of anemia with darbepoetin alfa in systolic heart failure, file dfa8b991-2c87-748b-e053-3a05fe0a3a96
|
249
|
Cardiopulmonary exercise testing for heart failure patients : a hodgepodge of techniques, parameters and interpretations. In other words, the need for a time-break, file dfa8b990-56e7-748b-e053-3a05fe0a3a96
|
248
|
Effect of acute β-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure, file dfa8b990-44e4-748b-e053-3a05fe0a3a96
|
244
|
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use, file dfa8b9a2-db98-748b-e053-3a05fe0a3a96
|
242
|
Effects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamics, file dfa8b991-341f-748b-e053-3a05fe0a3a96
|
237
|
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies, file dfa8b9a3-c694-748b-e053-3a05fe0a3a96
|
236
|
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study, file dfa8b9a4-5b50-748b-e053-3a05fe0a3a96
|
216
|
Management of heart failure in the new era : The role of scores, file dfa8b995-e872-748b-e053-3a05fe0a3a96
|
212
|
Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry, file dfa8b9a0-273e-748b-e053-3a05fe0a3a96
|
202
|
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure, file dfa8b99e-7927-748b-e053-3a05fe0a3a96
|
201
|
Choosing among β-blockers in heart failure patients according to β-receptors' location and functions in the cardiopulmonary system, file dfa8b9a2-204f-748b-e053-3a05fe0a3a96
|
199
|
A non invasive estimate of dead space ventilation from exercise measurements, file dfa8b991-2e43-748b-e053-3a05fe0a3a96
|
192
|
Effect of acute β-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure, file dfa8b990-431a-748b-e053-3a05fe0a3a96
|
189
|
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study, file dfa8b99a-0c1a-748b-e053-3a05fe0a3a96
|
186
|
Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes, file dfa8b99f-12ac-748b-e053-3a05fe0a3a96
|
185
|
The role of cardiopulmonary exercise tests in pulmonary arterial hypertension, file dfa8b99b-46ab-748b-e053-3a05fe0a3a96
|
181
|
Improvement in exercise capacity and delayed anaerobic metabolism induced by far-infrared-emitting garments in active healthy subjects : A pilot study, file dfa8b99b-46ac-748b-e053-3a05fe0a3a96
|
175
|
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue, file dfa8b99a-b5d5-748b-e053-3a05fe0a3a96
|
172
|
What's behind your eosinophilic myocarditis? A case of Churg–Strauss syndrome diagnosed during acute heart failure, file 955b5f89-f462-4c27-82ef-8c80d30eb46d
|
171
|
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure : data from the MECKI Score Research Group, file dfa8b997-56fe-748b-e053-3a05fe0a3a96
|
170
|
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction, file dfa8b996-04ce-748b-e053-3a05fe0a3a96
|
168
|
Upward Shift and Steepening of the Blood Pressure Response to Exercise in Hypertensive Subjects at High Altitude, file dfa8b99b-68ab-748b-e053-3a05fe0a3a96
|
164
|
Exertional dyspnoea in cardiorespiratory disorders : The clinical use of cardiopulmonary exercise testing, file dfa8b997-6e94-748b-e053-3a05fe0a3a96
|
162
|
Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure : implications for protein function, file dfa8b992-6b07-748b-e053-3a05fe0a3a96
|
161
|
Risk stratification in cardiomyopathy, file dfa8b9a4-d6a3-748b-e053-3a05fe0a3a96
|
161
|
Exertional dyspnoea in chronic heart failure : the role of the lung and respiratory mechanical factors, file dfa8b997-1504-748b-e053-3a05fe0a3a96
|
160
|
Prognostic role of atrial fibrillation in patients affected by chronic heart failure : data from the MECKI score research group, file dfa8b993-00fd-748b-e053-3a05fe0a3a96
|
159
|
Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy: comparison of surgical versus hemodynamic procedure, file dfa8b990-4736-748b-e053-3a05fe0a3a96
|
154
|
Brisk walking can be a maximal effort in heart failure patients: a comparison of cardiopulmonary exercise and 6 min walking test cardiorespiratory data, file dfa8b9a9-31ae-748b-e053-3a05fe0a3a96
|
153
|
Linking cell function with perfusion : insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO), file dfa8b99b-cdce-748b-e053-3a05fe0a3a96
|
148
|
The MECKI score initiative: Development and state of the art, file dfa8b9a5-02e0-748b-e053-3a05fe0a3a96
|
148
|
Levosimendan improves exercise performance in patients with advanced chronic heart failure, file dfa8b997-5ae4-748b-e053-3a05fe0a3a96
|
147
|
Exercise ventilatory inefficiency in heart failure : some fresh news into the roadmap of heart failure with preserved ejection fraction phenotyping, file dfa8b999-f5f6-748b-e053-3a05fe0a3a96
|
147
|
Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans, file dfa8b991-300f-748b-e053-3a05fe0a3a96
|
146
|
Exercise gas exchange in continuous-flow left ventricular assist device recipients, file dfa8b99c-2b03-748b-e053-3a05fe0a3a96
|
146
|
Effects of blood transfusion on exercise capacity in thalassemia major patients, file dfa8b993-0017-748b-e053-3a05fe0a3a96
|
137
|
Comparison of the diagnostic performance of 64-slice computed tomography coronary
angiography in diabetic and non-diabetic patients with suspected coronary artery
disease, file dfa8b98f-e85d-748b-e053-3a05fe0a3a96
|
135
|
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure, file dfa8b9a5-493b-748b-e053-3a05fe0a3a96
|
132
|
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions : A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine, file dfa8b99a-ba68-748b-e053-3a05fe0a3a96
|
131
|
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid, file dfa8b9a5-057c-748b-e053-3a05fe0a3a96
|
128
|
When a patent foramen ovale device is no more in place: silent patent foramen ovale occluder device migration to the aortic arch, file dfa8b99e-956d-748b-e053-3a05fe0a3a96
|
124
|
Rest and exercise oxygen uptake and cardiac output changes 6 months after successful transcatheter mitral valve repair, file dfa8b9a9-396f-748b-e053-3a05fe0a3a96
|
124
|
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure : Application of Metabolic Exercise Cardiac Kidney Indexes Score, file dfa8b994-dc74-748b-e053-3a05fe0a3a96
|
114
|
Negative Effect of Biventricular Pacing on Right Ventricular Function: A Case Report, file dfa8b9a4-7044-748b-e053-3a05fe0a3a96
|
111
|
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction, file dfa8b9a1-07d0-748b-e053-3a05fe0a3a96
|
110
|
SARS-CoV-2 spread in Northern Italy: what about the pollution role?, file dfa8b9a2-5f9b-748b-e053-3a05fe0a3a96
|
110
|
Peak exercise cardiac output but not oxygen uptake increases in all heart failure patients after successful resynchronization therapy, file dfa8b9a4-a40f-748b-e053-3a05fe0a3a96
|
108
|
Surfactant-derived proteins as markers of alveolar membrane damage in heart failure, file dfa8b992-7ac6-748b-e053-3a05fe0a3a96
|
105
|
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study, file dfa8b9a8-1dcc-748b-e053-3a05fe0a3a96
|
104
|
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure, file 794a6ebc-ddfe-4f7d-84d7-63ab4d8c02b8
|
98
|
The MECKI score initiative: a successful and ongoing story, file dfa8b9a4-d6aa-748b-e053-3a05fe0a3a96
|
98
|
The semantic of a pandemic: Are cardiovascular patients dying "with" or "from" COVID-19? Reflections from a case report, file dfa8b9a6-ae3b-748b-e053-3a05fe0a3a96
|
98
|
Pulmonary embolism in patients with COVID‑19: characteristics and outcomes in the Cardio‑COVID Italy multicenter study, file dfa8b9a4-0958-748b-e053-3a05fe0a3a96
|
96
|
A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza Score, file dfa8b9a7-1506-748b-e053-3a05fe0a3a96
|
95
|
Improvement in exercise capacity and delayed anaerobic metabolism induced by far-infrared-emitting garments in active healthy subjects : A pilot study, file dfa8b9a7-37e1-748b-e053-3a05fe0a3a96
|
94
|
S-Thiolation Targets Albumin in Heart Failure, file dfa8b9a3-57a5-748b-e053-3a05fe0a3a96
|
91
|
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy : Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction, file dfa8b9a0-2ef3-748b-e053-3a05fe0a3a96
|
90
|
Cardiac output changes during exercise in heart failure patients: focus on mid-exercise, file dfa8b9a4-f6ed-748b-e053-3a05fe0a3a96
|
88
|
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy, file dfa8b99b-2c86-748b-e053-3a05fe0a3a96
|
84
|
Lung function evaluation in heart failure: possible pitfalls, file dfa8b9a2-a42b-748b-e053-3a05fe0a3a96
|
83
|
Multiplexed MRM-Based Proteomics Identified Multiple Biomarkers of Disease Severity in Human Heart Failure, file dfa8b9a5-be00-748b-e053-3a05fe0a3a96
|
83
|
Exercise-induced cardiac costraint by the lungs, file dfa8b9a2-a72e-748b-e053-3a05fe0a3a96
|
82
|
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study, file dfa8b9a7-6091-748b-e053-3a05fe0a3a96
|
82
|
Variability in pulmonary diffusing capacity in heart failure, file dfa8b9a2-613d-748b-e053-3a05fe0a3a96
|
80
|
Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients, file dfa8b9a5-97c5-748b-e053-3a05fe0a3a96
|
80
|
In-depth age and ale profiling of human albumin in heart failure : Ex vivo studies, file dfa8b9a8-21e8-748b-e053-3a05fe0a3a96
|
80
|
N-acetyl-cysteine regenerates albumin cys34 by a thiol-disulfide breaking mechanism: An explanation of its extracellular antioxidant activity, file dfa8b9a2-566f-748b-e053-3a05fe0a3a96
|
78
|
Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial, file dfa8b9a2-6289-748b-e053-3a05fe0a3a96
|
76
|
A New Pathophysiology in Heart Failure Patients, file dfa8b9a2-b0b0-748b-e053-3a05fe0a3a96
|
74
|
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study, file dfa8b9a7-0ad6-748b-e053-3a05fe0a3a96
|
73
|
Prognostic role of beta-blocker selectivity and dosage regimens in heart failure patients : Insights from the MECKI score database, file dfa8b999-4813-748b-e053-3a05fe0a3a96
|
70
|
Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study, file dfa8b9a2-8ece-748b-e053-3a05fe0a3a96
|
69
|
Risk Stratification in Hypertrophic Cardiomyopathy : Insights from Genetic Analysis and Cardiopulmonary Exercise Testing, file dfa8b9a2-dd5d-748b-e053-3a05fe0a3a96
|
68
|
Validation of a new wearable device for type 3 sleep test without flowmeter, file dfa8b9a7-154f-748b-e053-3a05fe0a3a96
|
68
|
Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient, file dfa8b9a7-667e-748b-e053-3a05fe0a3a96
|
68
|
Lungs in heart failure, file dfa8b991-311a-748b-e053-3a05fe0a3a96
|
67
|
Totale |
23.365 |